Nasdaq · Healthcare
Jin Medical International Ltd. (ZJYL)
As-reported financials and recent SEC filings for Jin Medical International Ltd., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$20.7M
Net income
$1.2M
Net margin
5.8%
Diluted EPS
$0.01
ROE
4.0%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2023 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $20.7M | $23.5M | $19.8M | $19.2M | $20.8M |
| Gross profit | $6.0M | $9.5M | $6.8M | $6.2M | $6.4M |
| Operating income | $608,182 | $3.6M | $2.9M | $2.1M | $2.6M |
| Net income | $1.2M | $3.7M | $2.9M | $2.7M | $2.6M |
| Diluted EPS | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
6-K/A2026-06-30
View on EDGAR →6-K2026-06-29
View on EDGAR →6-K2026-06-04
View on EDGAR →32026-05-06
View on EDGAR →32026-04-27
View on EDGAR →32026-04-24
View on EDGAR →32026-04-24
View on EDGAR →32026-04-24
View on EDGAR →Largest Healthcare peers
Go deeper on ZJYL
Search Jin Medical International Ltd.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.